StockData
ANEBOTCPharmaceutical PreparationsFiscal year ends June 30

Anebulo Pharmaceuticals, Inc.

Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026
$0.00+0.00 (+75.00%)

Close on Oct 19, 2026

Market cap
$28.76K
P/E (TTM)
–
Dividend yield
–

Anebulo Pharmaceuticals, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Anebulo Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.